USARx offers the following ways to purchase this medication. Choose the Best option for you!
Yes82% of Medicare Part D and Medicare Advantage plans cover this drug.
It depends. Which coverage stage are you in? Click on a tab below…
$7 – $109
In the Deductible co-pay stage, you are responsible for the full cost of your prescriptions. Your Medicare deductible cannot exceed $360 in 2016.
Here are some ways that may lower the cost of your nadolol prescription.
If your Medicare co-pay is higher, you can save money by using a USARx coupon instead.
Applies to nadolol: oral tablet
Oral route (Tablet)
Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. The dosage should be gradually reduced over a period of 1 to 2 weeks and the patient should be carefully monitored when discontinuing chronic therapy, particularly in patients with ischemic heart disease. If angina markedly worsens or acute coronary insufficiency develops, nadolol administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician's advice.
Along with its needed effects, nadolol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking nadolol:
Some side effects of nadolol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
For Healthcare Professionals
Applies to nadolol: compounding powder, oral tabletGeneral
The most common adverse reactions were bradycardia, cardiac failure, rhythm/conduction disturbances, symptoms of peripheral vascular insufficiency, hypotension, dizziness, and fatigue.Cardiovascular
Common (1% to 10%): Heart rate less than 60 beats per minute (bpm), heart rate less than 40 bpm, cardiac failure, rhythm/conduction disturbances, symptoms of peripheral vascular insufficiency usually of the Raynaud type, hypotension
Frequency not reported: First degree and third degree heart block, cold extremitiesNervous system
Common (1% to 10%): Dizziness
Uncommon (0.1% to 1%): Paresthesias, sedation, headache, slurred speech, tinnitus
Frequency not reported: LightheadednessOther
Common (1% to 10%): FatigueGastrointestinal
Uncommon (0.1% to 1%): Nausea, diarrhea, abdominal discomfort, constipation, vomiting, indigestion, bloating, flatulence, dry mouthDermatologic
Uncommon (0.1% to 1%): Rash, pruritus, dry skin, sweating, facial swelling
Frequency not reported: Reversible alopeciaRespiratory
Uncommon (0.1% to 1%): Cough, nasal stuffiness, bronchospasmMetabolic
Uncommon (0.1% to 1%): Anorexia, weight gain
Frequency not reported: HypoglycemiaOcular
Uncommon (0.1% to 1%): Dry eyes, blurred visionPsychiatric
Uncommon (0.1% to 1%): Change in behavior
Frequency not reported: InsomniaGenitourinary
Uncommon (0.1% to 1%): Impotence or decreased libido
December 16, 2020
March 1, 2021
February 15, 2021
March 1, 2021
February 1, 2021
January 31, 2021